Granulomatosis with Polyangiitis - 51 Studies Found
Completed |
: Etanercept for Wegener's Granulomatosis : Wegener's Granulomatosis : 2000-03-24 : Drug: Etanercept |
Active, not recruiting |
: An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis :
: 2012-06-04 : Drug: Rituximab Participants received rituximab at the discretion of their treating physicians. |
Completed |
: Study of One Protein Implicated in Wegener Disease : Wegener's Granulomatosis : 2010-07-12 : Biological: Physiopathology Endpoint Classification Blood samples will be collected during a routine med |
Completed |
: Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis : Wegener's Granulomatosis : 2007-09-14 : Drug: Gusperimus SC, 0.5mg/kg/day, consecutive 21 days administration, 1 to 2 weeks rest, 6 cycles |
Completed |
: Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis : Wegener's Granulomatosis : 2007-04-30 : Drug: Abatacept A participant's abatacept dose depended on |
Recruiting |
: Determining Disease Activity Biomarkers in Individuals With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) :
|
Completed |
: Daclizumab to Treat Wegener's Granulomatosis : Wegener's Granulomatosis : 2002-06-22 : Drug: Daclizumab |
Completed |
: An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies : Wegener's Granulomatosis : 2003-11-04 : Drug: Rituximab |
Recruiting |
: Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis :
: 2006-04-14 |
Recruiting |
: Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) :
|